200 related articles for article (PubMed ID: 25921661)
41. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.
Seki S; Sakaguchi H; Kitada T; Tamori A; Takeda T; Kawada N; Habu D; Nakatani K; Nishiguchi S; Shiomi S
Clin Cancer Res; 2000 Sep; 6(9):3469-73. PubMed ID: 10999730
[TBL] [Abstract][Full Text] [Related]
42. Vascular immunohistochemical markers: contributions to hepatocellular nodule diagnosis in explanted livers.
Nascimento C; Caroli-Bottino A; Paschoal J; Pannain VL
Transplant Proc; 2009 Dec; 41(10):4211-3. PubMed ID: 20005371
[TBL] [Abstract][Full Text] [Related]
43. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
Singhi AD; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson M
Am J Surg Pathol; 2012 May; 36(5):710-5. PubMed ID: 22498821
[TBL] [Abstract][Full Text] [Related]
44. Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma.
Kim H; Park YN
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):813-29. PubMed ID: 25260310
[TBL] [Abstract][Full Text] [Related]
45. [Advances in the diagnostic pathological features of precancerous lesions of hepatocellular carcinoma].
Zhao YQ; Cong WM
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):491-493. PubMed ID: 31357773
[TBL] [Abstract][Full Text] [Related]
46. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
Hanif R; Mansoor S
J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
[TBL] [Abstract][Full Text] [Related]
47. Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis.
Wee A
Cytopathology; 2011 Oct; 22(5):287-305. PubMed ID: 21762411
[TBL] [Abstract][Full Text] [Related]
48. [Hepatic cell dysplasia. A pre-malignant lesion related to hepatocellular carcinoma and infection by hepatitis B virus].
de Queiroz AC; Moreira DE; Andrade ML
Arq Gastroenterol; 1987; 24(2):80-3. PubMed ID: 2849924
[TBL] [Abstract][Full Text] [Related]
49. [Hepatocellular carcinoma--from macroscopy to molecular pathology].
Schaff Z; Kovalszky I; Lotz G; Kiss A
Orv Hetil; 2010 Jun; 151(24):982-9. PubMed ID: 20519181
[TBL] [Abstract][Full Text] [Related]
50. [Update on hepatocellular nodular lesions].
Chen QR; Wei SZ
Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):412-6. PubMed ID: 24060081
[No Abstract] [Full Text] [Related]
51. Differential diagnosis of hepatocellular nodular lesions.
Hytiroglou P; Theise ND
Semin Diagn Pathol; 1998 Nov; 15(4):285-99. PubMed ID: 9845429
[TBL] [Abstract][Full Text] [Related]
52. Outcome of 51 nonmalignant nodules in the liver: usefulness of aspiration cytology for diagnosis of dysplastic nodules.
Kaji I; Kasugai H; Takenaka A; Ishikawa H; Inoue A; Iishi H; Ishiguro S; Tatsuta M
J Exp Clin Cancer Res; 2004 Sep; 23(3):425-31. PubMed ID: 15595631
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.
Enan ET; El-Hawary AK; El-Tantawy DA; Abu-Hashim MM; Helal NM
Ann Diagn Pathol; 2013 Dec; 17(6):490-3. PubMed ID: 24012547
[TBL] [Abstract][Full Text] [Related]
54. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma.
Takayama T; Makuuchi M; Hirohashi S; Sakamoto M; Okazaki N; Takayasu K; Kosuge T; Motoo Y; Yamazaki S; Hasegawa H
Lancet; 1990 Nov; 336(8724):1150-3. PubMed ID: 1978027
[TBL] [Abstract][Full Text] [Related]
55. Some cytologic features of hepatocellular carcinoma as seen in fine needle aspirates.
Greene CA; Suen KC
Acta Cytol; 1984; 28(6):713-8. PubMed ID: 6095567
[TBL] [Abstract][Full Text] [Related]
56. [Nodular hepatocellular lesions. Guidelines and minimal diagnostic criteria for gastrointestinal histopathological diagnosis. Gruppo Italiano Patologi dell'Apparato Digerente].
Roncalli M; David E; Gentile A; Pollice L
Pathologica; 2000 Jun; 92(3):210-20. PubMed ID: 10902435
[No Abstract] [Full Text] [Related]
57. Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine.
Vyas M; Zhang X
Clin Liver Dis; 2020 Nov; 24(4):591-610. PubMed ID: 33012447
[TBL] [Abstract][Full Text] [Related]
58. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view.
Kojiro M
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S3-8. PubMed ID: 14762831
[TBL] [Abstract][Full Text] [Related]
59. A rapid method for obtaining hematoxylin and eosin biopsy sections of bone for table diagnosis.
VILLANUEVA AR; FROST HM
Am J Clin Pathol; 1961 Jul; 36():54-9. PubMed ID: 13781400
[No Abstract] [Full Text] [Related]
60. Broadsheet number 47: Chronic hepatitis: an update with guidelines for histopathological assessment of liver biopsies. Board of Education of The Royal College of Pathologists of Australasia.
Hall PD
Pathology; 1998 Nov; 30(4):369-80. PubMed ID: 9839312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
